163 related articles for article (PubMed ID: 17961802)
1. Polymorphisms in the survivin gene and the risk of lung cancer.
Jang JS; Kim KM; Kang KH; Choi JE; Lee WK; Kim CH; Kang YM; Kam S; Kim IS; Jun JE; Jung TH; Park JY
Lung Cancer; 2008 Apr; 60(1):31-39. PubMed ID: 17961802
[TBL] [Abstract][Full Text] [Related]
2. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma.
Yang X; Xiong G; Chen X; Xu X; Wang K; Fu Y; Yang K; Bai Y
J Cancer Res Clin Oncol; 2009 Oct; 135(10):1341-9. PubMed ID: 19352701
[TBL] [Abstract][Full Text] [Related]
4. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
5. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
Cheng ZJ; Hu LH; Huang SJ
Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
[TBL] [Abstract][Full Text] [Related]
6. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
[TBL] [Abstract][Full Text] [Related]
7. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
[TBL] [Abstract][Full Text] [Related]
8. DNMT3B polymorphisms and risk of primary lung cancer.
Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
[TBL] [Abstract][Full Text] [Related]
9. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
Jaiswal PK; Goel A; Mandhani A; Mittal RD
Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
[TBL] [Abstract][Full Text] [Related]
11. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
[TBL] [Abstract][Full Text] [Related]
12. BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
Hmeljak J; Erčulj N; Dolžan V; Kern I; Cör A
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1641-51. PubMed ID: 21861135
[TBL] [Abstract][Full Text] [Related]
13. Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population.
Kang HG; Lee SJ; Chae MH; Lee WK; Cha SI; Kim CH; Kam S; Park RW; Kim IS; Kim DS; Kim YC; Jung TH; Park JY
Cancer Genet Cytogenet; 2008 Jan; 180(1):6-13. PubMed ID: 18068526
[TBL] [Abstract][Full Text] [Related]
14. Survivin polymorphisms and susceptibility to prostate cancer: A genetic association study and an
Karimian M; Aftabi Y; Mazoochi T; Babaei F; Khamechian T; Boojari H; Nikzad H
EXCLI J; 2018; 17():479-491. PubMed ID: 30034311
[TBL] [Abstract][Full Text] [Related]
15. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
[TBL] [Abstract][Full Text] [Related]
16. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
Srivastava K; Srivastava A; Mittal B
Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
[TBL] [Abstract][Full Text] [Related]
17. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
Javid J; Mir R; Julka PK; Ray PC; Saxena A
Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
[TBL] [Abstract][Full Text] [Related]
18. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk.
Jang JS; Kim KM; Choi JE; Cha SI; Kim CH; Lee WK; Kam S; Jung TH; Park JY
Mol Carcinog; 2008 May; 47(5):383-90. PubMed ID: 18058802
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population.
Han SG; Park KH; Sung JS; Whang YM; Kim YJ; Shin ES; Lee JW; Lee HJ; Ryu JS; Choi IK; Seo JH; Kim YH
Lung Cancer; 2008 Nov; 62(2):152-61. PubMed ID: 18450319
[TBL] [Abstract][Full Text] [Related]
20. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
